191 related articles for article (PubMed ID: 21594979)
1. Developmental toxicity of Citrus aurantium in rats.
Hansen DK; Juliar BE; White GE; Pellicore LS
Birth Defects Res B Dev Reprod Toxicol; 2011 Jun; 92(3):216-23. PubMed ID: 21594979
[TBL] [Abstract][Full Text] [Related]
2. Physiological effects following administration of Citrus aurantium for 28 days in rats.
Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular toxicity of Citrus aurantium in exercised rats.
Hansen DK; George NI; White GE; Abdel-Rahman A; Pellicore LS; Fabricant D
Cardiovasc Toxicol; 2013 Sep; 13(3):208-19. PubMed ID: 23397375
[TBL] [Abstract][Full Text] [Related]
4. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats.
Arbo MD; Franco MT; Larentis ER; Garcia SC; Sebben VC; Leal MB; Dallegrave E; Limberger RP
Arch Toxicol; 2009 Jan; 83(1):95-9. PubMed ID: 18651134
[TBL] [Abstract][Full Text] [Related]
5. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
Stohs SJ
Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
[TBL] [Abstract][Full Text] [Related]
6. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
[TBL] [Abstract][Full Text] [Related]
7. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
[TBL] [Abstract][Full Text] [Related]
8. Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice.
Arbo MD; Schmitt GC; Limberger MF; Charão MF; Moro AM; Ribeiro GL; Dallegrave E; Garcia SC; Leal MB; Limberger RP
Regul Toxicol Pharmacol; 2009 Jul; 54(2):114-7. PubMed ID: 19275924
[TBL] [Abstract][Full Text] [Related]
9. Citrus aurantium (bitter orange) extract: Safety assessment by acute and 14-day oral toxicity studies in rats and the Ames Test for mutagenicity.
Deshmukh NS; Stohs SJ; Magar CC; Kadam SB
Regul Toxicol Pharmacol; 2017 Nov; 90():318-327. PubMed ID: 28966104
[TBL] [Abstract][Full Text] [Related]
10. Toxicological effects of a mixture used in weight loss products: p-synephrine associated with ephedrine, salicin, and caffeine.
Schmitt GC; Arbo MD; Lorensi AL; Maciel ES; Krahn CL; Mariotti KC; Dallegrave E; Leal MB; Limberger RP
Int J Toxicol; 2012 Mar; 31(2):184-91. PubMed ID: 22408069
[TBL] [Abstract][Full Text] [Related]
11. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
Kaats GR; Miller H; Preuss HG; Stohs SJ
Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
[TBL] [Abstract][Full Text] [Related]
12. Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on metabolic fluxes in the rat liver.
Peixoto JS; Comar JF; Moreira CT; Soares AA; de Oliveira AL; Bracht A; Peralta RM
Molecules; 2012 May; 17(5):5854-69. PubMed ID: 22592089
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
Shara M; Stohs SJ; Mukattash TL
Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
[TBL] [Abstract][Full Text] [Related]
14. Bitter orange (
Deshmukh NS; Stohs SJ; Magar CC; Kale A; Sowmya B
Toxicol Rep; 2017; 4():598-613. PubMed ID: 29214145
[TBL] [Abstract][Full Text] [Related]
15. Review of Published Bitter Orange Extract and
Stohs SJ; Ray SD
J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
[No Abstract] [Full Text] [Related]
16. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
Perova IB; Eller KI; Musatov AV; Tymolskaya EV
Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.
Arbo MD; Larentis ER; Linck VM; Aboy AL; Pimentel AL; Henriques AT; Dallegrave E; Garcia SC; Leal MB; Limberger RP
Food Chem Toxicol; 2008 Aug; 46(8):2770-5. PubMed ID: 18571300
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans.
Seifert JG; Nelson A; Devonish J; Burke ER; Stohs SJ
Int J Med Sci; 2011 Mar; 8(3):192-7. PubMed ID: 21448304
[TBL] [Abstract][Full Text] [Related]
19. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
[TBL] [Abstract][Full Text] [Related]
20. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research.
Fugh-Berman A; Myers A
Exp Biol Med (Maywood); 2004 Sep; 229(8):698-704. PubMed ID: 15337824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
